Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Terminal Cancer × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3640 Neoplasms 2522 Prostatic Neoplasms 1599 Colorectal Neoplasms 1449 Lung Neoplasms 1284 Carcinoma, Non-Small-Cell Lung 1055 Pancreatic Neoplasms 823 Multiple Myeloma 794 Leukemia, Myeloid, Acute 792 Lymphoma 764 Head and Neck Neoplasms 732 Leukemia 707 Precursor Cell Lymphoblastic Leukemia-Lymphoma 675 Neoplasm Metastasis 652 Ovarian Neoplasms 643 Colonic Neoplasms 641 Carcinoma, Hepatocellular 631 Stomach Neoplasms 623 Melanoma 621 Brain Neoplasms 597 Rectal Neoplasms 587 Lymphoma, Non-Hodgkin 544 Uterine Cervical Neoplasms 508 Leukemia, Lymphocytic, Chronic, B-Cell 502 Glioblastoma 463 Esophageal Neoplasms 454 Lymphoma, Follicular 451 Recurrence 448 Hodgkin Disease 446 Myelodysplastic Syndromes 430

Interventions

Midazolam 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02009306 2018-05-09

Nasal Fentanyl and Buccal Midazolam for Dying Patients

Gloucestershire Hospitals NHS Foundation Trust

Phase 4 Completed

Terminal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡